HLB Therapeutics Co Ltd Sustainability Reports
HLB Therapeutics Co., Ltd. is a South Korea-based biopharmaceutical enterprise focused on the clinical development of therapies for neurotrophic keratitis and glioblastoma, alongside managing vaccine cold chain logistics.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSDAQ)
FIGI: BBG001T6V436
1 reports from 2025 to 2025
